$SGBX
SAFE & GREEN HOLDINGS CORP.

2024 Q4 Form 10-Q Financial Statement

#000121390024102979 Filed on November 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.753M
YoY Change -55.79%
Cost Of Revenue $1.879M
YoY Change -58.26%
Gross Profit -$125.6K
YoY Change -76.57%
Gross Profit Margin -7.16%
Selling, General & Admin $353.7K
YoY Change -78.16%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $104.8K
YoY Change 12.75%
% of Gross Profit
Operating Expenses $2.116M
YoY Change -13.27%
Operating Profit -$2.241M
YoY Change -24.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.475M
YoY Change 133.02%
Pretax Income -$3.716M
YoY Change 2.99%
Income Tax
% Of Pretax Income
Net Earnings -$3.716M
YoY Change 2.99%
Net Earnings / Revenue -211.96%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 4.393M shares 2.028M shares
Diluted Shares Outstanding 2.089M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $257.0K
Short-Term Investments
Other Short-Term Assets $1.919M
YoY Change -52.03%
Inventory $742.1K
Prepaid Expenses
Receivables $168.2K
Other Receivables
Total Short-Term Assets $2.001M
YoY Change -71.83%
LONG-TERM ASSETS
Property, Plant & Equipment $4.206M
YoY Change -39.05%
Goodwill
YoY Change
Intangibles $15.08K
YoY Change -99.23%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.798M
YoY Change -57.23%
TOTAL ASSETS
Total Short-Term Assets $2.001M
Total Long-Term Assets $7.798M
Total Assets $9.799M
YoY Change -61.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $755.1K
YoY Change -42.41%
Short-Term Debt
YoY Change
Long-Term Debt Due $1.846M
YoY Change 710.37%
Total Short-Term Liabilities $13.24M
YoY Change -15.59%
LONG-TERM LIABILITIES
Long-Term Debt $4.720M
YoY Change 62.93%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.720M
YoY Change 45.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.24M
Total Long-Term Liabilities $4.720M
Total Liabilities $17.96M
YoY Change -5.07%
SHAREHOLDERS EQUITY
Retained Earnings -$87.44M
YoY Change 40.29%
Common Stock $22.58K
YoY Change -86.3%
Preferred Stock
YoY Change
Treasury Stock (at cost) $92.40K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $9.799M
YoY Change -61.32%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$3.716M
YoY Change 2.99%
Depreciation, Depletion And Amortization $104.8K
YoY Change 12.75%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2115509 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
675931 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2024#AffiliatedEntityMember
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2024#AffiliatedEntityMember
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001023994
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-1.15
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
1.87
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-3.54
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38037
dei Entity Registrant Name
EntityRegistrantName
SAFE & GREEN HOLDINGS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4463937
dei Entity Address Address Line1
EntityAddressAddressLine1
990 Biscayne Blvd.,
dei Entity Address Address Line2
EntityAddressAddressLine2
#501, Office 12
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33132
dei City Area Code
CityAreaCode
(646)
dei Local Phone Number
LocalPhoneNumber
240-4235
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SGBX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4392723 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256957 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14212 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
168240 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182753 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
184520 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10745 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
742144 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
156512 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
649001 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
340790 usd
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
4635586 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2000862 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5340598 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4206315 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4388177 usd
CY2024Q3 sgbx Project Development Costs And Other Non Current Assets
ProjectDevelopmentCostsAndOtherNonCurrentAssets
693078 usd
CY2023Q4 sgbx Project Development Costs And Other Non Current Assets
ProjectDevelopmentCostsAndOtherNonCurrentAssets
538989 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1120337 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1987137 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15075 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1406 usd
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
30589 usd
CY2024Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1763594 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
4924379 usd
CY2024Q3 us-gaap Assets
Assets
9799261 usd
CY2023Q4 us-gaap Assets
Assets
17211275 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8653998 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8992971 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
755064 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1366998 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
265627 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
856088 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1717694 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2024Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1845611 usd
CY2023Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1661183 usd
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
7672189 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13237994 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20549429 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
4720194 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2447415 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
549290 usd
CY2024Q3 us-gaap Liabilities
Liabilities
17958188 usd
CY2023Q4 us-gaap Liabilities
Liabilities
23546134 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2258103 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2258103 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
881387 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
814969 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
22581 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8814 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
79353348 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69003597 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3371 shares
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3371 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
92396 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
92396 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87442460 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75930805 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8158927 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6334859 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9799261 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17211275 usd
CY2024Q3 us-gaap Revenues
Revenues
1753223 usd
CY2023Q3 us-gaap Revenues
Revenues
3965361 usd
us-gaap Revenues
Revenues
3932592 usd
us-gaap Revenues
Revenues
14566351 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1878799 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
4501393 usd
us-gaap Cost Of Revenue
CostOfRevenue
3618031 usd
us-gaap Cost Of Revenue
CostOfRevenue
15138225 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
-125576 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-536032 usd
us-gaap Gross Profit
GrossProfit
314561 usd
us-gaap Gross Profit
GrossProfit
-571874 usd
CY2024Q3 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
1761827 usd
CY2023Q3 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
591130 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
3507118 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
5419852 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
275156 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1012662 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1513100 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3638803 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
78526 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
251309 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
316270 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
414154 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1855101 usd
us-gaap Operating Expenses
OperatingExpenses
5336488 usd
us-gaap Operating Expenses
OperatingExpenses
9472809 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2241085 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2391133 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5021927 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10044683 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
864007 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
398772 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2404277 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
735070 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3186 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
9570 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
22002 usd
CY2024Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2023Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-320408 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2024Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-613665 usd
CY2023Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-5590666 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2652 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
102128 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
186634 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
690618 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1475020 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-293458 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8119147 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22450 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3716105 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2684591 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13141074 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10067133 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3716105 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2684591 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13141074 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10067133 usd
CY2024Q3 sgbx Common Stock Deemed Dividends For Reduction In Conversion Rate
CommonStockDeemedDividendsForReductionInConversionRate
usd
CY2023Q3 sgbx Common Stock Deemed Dividends For Reduction In Conversion Rate
CommonStockDeemedDividendsForReductionInConversionRate
usd
sgbx Common Stock Deemed Dividends For Reduction In Conversion Rate
CommonStockDeemedDividendsForReductionInConversionRate
475713 usd
sgbx Common Stock Deemed Dividends For Reduction In Conversion Rate
CommonStockDeemedDividendsForReductionInConversionRate
usd
CY2024Q3 sgbx Common Stock Deemed Dividends For Inducement
CommonStockDeemedDividendsForInducement
usd
CY2023Q3 sgbx Common Stock Deemed Dividends For Inducement
CommonStockDeemedDividendsForInducement
usd
sgbx Common Stock Deemed Dividends For Inducement
CommonStockDeemedDividendsForInducement
670881 usd
sgbx Common Stock Deemed Dividends For Inducement
CommonStockDeemedDividendsForInducement
usd
CY2024Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-3716105 usd
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-2684591 usd
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-14287668 usd
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-10067133 usd
CY2024Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
usd
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-923543 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
2776013 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-2615965 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3716105 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3608134 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11511655 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12683098 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.78
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.78
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.34
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.34
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-9.61
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-9.61
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-13.64
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-13.64
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-1.15
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
1.87
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-3.54
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2089478 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2089478 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
802857 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
802857 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1486059 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1486059 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
738075 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
738075 shares
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5661778 usd
CY2024Q3 sgbx Stock Issued During Period Value For Accounts Payable Settlement
StockIssuedDuringPeriodValueForAccountsPayableSettlement
648579 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
570362 usd
CY2024Q3 sgbx Stock Issued During Period Value Prefunded Warrant Exercise
StockIssuedDuringPeriodValuePrefundedWarrantExercise
15 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3716105 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8158927 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6334859 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1097698 usd
sgbx Stock Issued During Period Value Prefunded Warrant Exercise
StockIssuedDuringPeriodValuePrefundedWarrantExercise
30 usd
sgbx Stock Issued During Period Value Warrant Inducement
StockIssuedDuringPeriodValueWarrantInducement
494213 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
251361 usd
sgbx Stock Issued During Period Value Conversion Of Debt And Interest
StockIssuedDuringPeriodValueConversionOfDebtAndInterest
802087 usd
sgbx Stock Issued During Period Value Under Economic Partnership Agreement
StockIssuedDuringPeriodValueUnderEconomicPartnershipAgreement
28867 usd
sgbx Stock Issued During Period Value For Accounts Payable Settlement
StockIssuedDuringPeriodValueForAccountsPayableSettlement
1259681 usd
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2983518 usd
us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1966848 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3590386 usd
us-gaap Profit Loss
ProfitLoss
-10365061 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8158927 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9325160 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
700000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3608134 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6417026 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14439562 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3210631 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
437325 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
47500 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
354239 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
46417 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
42716 usd
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
700000 usd
us-gaap Profit Loss
ProfitLoss
-12683098 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6417026 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13141074 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10067133 usd
sgbx Income Loss From Discontinued Operations
IncomeLossFromDiscontinuedOperations
-2776013 usd
sgbx Income Loss From Discontinued Operations
IncomeLossFromDiscontinuedOperations
2615965 usd
us-gaap Depreciation
Depreciation
189869 usd
us-gaap Depreciation
Depreciation
277573 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10251 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
140437 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
30589 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
30589 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
611721 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
476894 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
866800 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
613092 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
4728348 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-320408 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-5590666 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
484825 usd
sgbx Interest Income On Long Term Note Receivable
InterestIncomeOnLongTermNoteReceivable
usd
sgbx Interest Income On Long Term Note Receivable
InterestIncomeOnLongTermNoteReceivable
21884 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1097698 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3210631 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14513 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-539157 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
173775 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-17993 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
585632 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-63374 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
308211 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-310150 usd
us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
23920 usd
us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
71761 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
881548 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2060288 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-611934 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
873731 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1139751 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-925815 usd
sgbx Increase Decrease In Assumed Liability Of Business Transferred
IncreaseDecreaseInAssumedLiabilityOfBusinessTransferred
usd
sgbx Increase Decrease In Assumed Liability Of Business Transferred
IncreaseDecreaseInAssumedLiabilityOfBusinessTransferred
15000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8322569 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4588824 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1593347 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-83039 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8007 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
522715 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
125000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
154089 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
110279 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-37096 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-632994 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-364352 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-59609 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
42716 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5143298 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
232144 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8013745 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1401339 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
706359 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
494213 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3590386 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
sgbx Proceeds From Issuance Of Common Stock Under Economic Partnership Agreement
ProceedsFromIssuanceOfCommonStockUnderEconomicPartnershipAgreement
28867 usd
sgbx Proceeds From Issuance Of Common Stock Under Economic Partnership Agreement
ProceedsFromIssuanceOfCommonStockUnderEconomicPartnershipAgreement
usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
46417 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6983943 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1786421 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
3576166 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
3708175 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
242745 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
130130 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14212 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
582776 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
256957 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
712906 usd
CY2024Q3 sgbx Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDiscontinuedOperations
usd
CY2023Q3 sgbx Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDiscontinuedOperations
-33365 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
256957 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
679541 usd
sgbx Cash Effected In Deconsolidation
CashEffectedInDeconsolidation
567473 usd
sgbx Cash Effected In Deconsolidation
CashEffectedInDeconsolidation
usd
sgbx Assets Held For Sale Effected In Deconsolidation
AssetsHeldForSaleEffectedInDeconsolidation
4400361 usd
sgbx Assets Held For Sale Effected In Deconsolidation
AssetsHeldForSaleEffectedInDeconsolidation
usd
sgbx Prepaid Expenses And Other Current Assets Effected In Deconsolidation
PrepaidExpensesAndOtherCurrentAssetsEffectedInDeconsolidation
429331 usd
sgbx Prepaid Expenses And Other Current Assets Effected In Deconsolidation
PrepaidExpensesAndOtherCurrentAssetsEffectedInDeconsolidation
usd
sgbx Property And Equipment Net Effected In Deconsolidation
PropertyAndEquipmentNetEffectedInDeconsolidation
1194117 usd
sgbx Property And Equipment Net Effected In Deconsolidation
PropertyAndEquipmentNetEffectedInDeconsolidation
usd
sgbx Project Development Costs And Other Assets Effected In Deconsolidation
ProjectDevelopmentCostsAndOtherAssetsEffectedInDeconsolidation
91490 usd
sgbx Project Development Costs And Other Assets Effected In Deconsolidation
ProjectDevelopmentCostsAndOtherAssetsEffectedInDeconsolidation
usd
sgbx Goodwill Effected In Deconsolidation
GoodwillEffectedInDeconsolidation
1810787 usd
sgbx Goodwill Effected In Deconsolidation
GoodwillEffectedInDeconsolidation
usd
sgbx Intangible Assets Effected In Deconsolidation
IntangibleAssetsEffectedInDeconsolidation
138678 usd
sgbx Intangible Assets Effected In Deconsolidation
IntangibleAssetsEffectedInDeconsolidation
usd
sgbx Investments In Equity Based Investments Effected In Deconsolidation
InvestmentsInEquityBasedInvestmentsEffectedInDeconsolidation
3642607 usd
sgbx Investments In Equity Based Investments Effected In Deconsolidation
InvestmentsInEquityBasedInvestmentsEffectedInDeconsolidation
usd
sgbx Accounts Payable And Accrued Expenses Effected In Deconsolidation
AccountsPayableAndAccruedExpensesEffectedInDeconsolidation
1600294 usd
sgbx Accounts Payable And Accrued Expenses Effected In Deconsolidation
AccountsPayableAndAccruedExpensesEffectedInDeconsolidation
usd
sgbx Contingent Consideration Payable Effected In Deconsolidation
ContingentConsiderationPayableEffectedInDeconsolidation
945000 usd
sgbx Contingent Consideration Payable Effected In Deconsolidation
ContingentConsiderationPayableEffectedInDeconsolidation
usd
sgbx Short Term Notes Payable Effected In Deconsolidation
ShortTermNotesPayableEffectedInDeconsolidation
6476723 usd
sgbx Short Term Notes Payable Effected In Deconsolidation
ShortTermNotesPayableEffectedInDeconsolidation
usd
sgbx Cashless Warrant Exercise
CashlessWarrantExercise
114 usd
sgbx Cashless Warrant Exercise
CashlessWarrantExercise
usd
sgbx Fractional Common Share Adjustment
FractionalCommonShareAdjustment
1 usd
sgbx Fractional Common Share Adjustment
FractionalCommonShareAdjustment
usd
sgbx Common Stock Deemed Dividends For Inducement
CommonStockDeemedDividendsForInducement
670881 usd
sgbx Common Stock Deemed Dividends For Inducement
CommonStockDeemedDividendsForInducement
usd
sgbx Common Stock Deemed Dividends For Reduction In Conversion Rate
CommonStockDeemedDividendsForReductionInConversionRate
475713 usd
sgbx Common Stock Deemed Dividends For Reduction In Conversion Rate
CommonStockDeemedDividendsForReductionInConversionRate
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
802087 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
700000 usd
sgbx Fair Value Of Warrants Issued With Debt
FairValueOfWarrantsIssuedWithDebt
251361 usd
sgbx Fair Value Of Warrants Issued With Debt
FairValueOfWarrantsIssuedWithDebt
usd
sgbx Common Stock Issued For Accounts Payable Settlement
CommonStockIssuedForAccountsPayableSettlement
1259681 usd
sgbx Common Stock Issued For Accounts Payable Settlement
CommonStockIssuedForAccountsPayableSettlement
usd
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
100468 usd
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
usd
sgbx Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
1810787 usd
sgbx Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
usd
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
532337 usd
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
usd
sgbx Noncash Or Part Noncash Acquisition Contingent Consideration Liabilities Assumed
NoncashOrPartNoncashAcquisitionContingentConsiderationLiabilitiesAssumed
945000 usd
sgbx Noncash Or Part Noncash Acquisition Contingent Consideration Liabilities Assumed
NoncashOrPartNoncashAcquisitionContingentConsiderationLiabilitiesAssumed
usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segments
CY2024Q3 sgbx Number Of Core Product Offerings
NumberOfCoreProductOfferings
3 item
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a 1-for-20 reverse stock split of its then-outstanding common stock (the “May Stock Split”). All share and per share amounts set forth in the consolidated financial statements of the Company have been retroactively restated to reflect the 1-for-20 reverse stock split as if it had occurred as of the earliest period presented and unless otherwise stated, all other share and per share amounts for all periods presented in this Quarterly Report on Form 10-Q for the period ended September 30, 2024 have been adjusted to reflect the reverse stock split effected in May 2024
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
4728348 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256957 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1919313 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1919313 usd
sgbx Working Capital
WorkingCapital
-9519438 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="font-size: 10pt;"> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 0pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><span style="border-left: none; border-right: none;"><span style="font-style: italic; font-weight: bold;">Reclassifications -</span> Certain amounts in the prior periods presented have been reclassified to conform to the current period financial statement presentation. These reclassifications have <span>no</span> effect on previously reported net loss or cash flows.</span></span></p> </div> </div> </div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="font-size: 10pt;"> <div style="border-left: none; border-right: none; text-align: justify; line-height: 1.2;"> <div> <div style="border-left: none; border-right: none;"> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="font-size: 10pt; line-height: inherit;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period, together with amounts disclosed in the related notes to the financial statements. <span style="font-family: 'times new roman', times; line-height: inherit;">The <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Company’s</span> estimates used in these financial statements include, but are not limited to, revenue recognition, stock-based compensation, accounts receivable reserves, inventory valuations, goodwill, the valuation allowance related to the Company’s deferred tax assets, the carrying amount of intangible assets, right of use assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span></span></span></span></span></p> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
sgbx No Of Operating Cycles
NoOfOperatingCycles
one year
sgbx Revenue Recognized Over Time
RevenueRecognizedOverTime
3932592 usd
sgbx Revenue Recognized Over Time
RevenueRecognizedOverTime
14566351 usd
CY2024Q3 sgbx Revenue Recognized Over Time
RevenueRecognizedOverTime
1753223 usd
CY2023Q3 sgbx Revenue Recognized Over Time
RevenueRecognizedOverTime
3965361 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1753223 usd
CY2024Q3 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3965361 usd
CY2023Q3 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3932592 usd
sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14566351 usd
sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2020Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
200000 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256957 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14212 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q3 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
68344 usd
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1880547 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
10251 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
140437 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
59975 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2852929 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; font-style: italic; font-weight: bold; line-height: inherit;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any </span><span style="font-family: 'Times New Roman'; line-height: inherit;">significant </span><span style="font-family: 'Times New Roman'; line-height: inherit;">credit risk on the account. <br/></span><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At <span>September 30, 2024</span> and <span>December 31, 2023</span>, 100% of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none; line-height: inherit;">four</span> and three customers, <span style="color: #000000; font-family: 'Times New Roman', 'serif'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">respectively.</span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Revenue relating to one customer represented approximately 84% and 100%, <span style="color: #000000; font-family: 'Times New Roman', 'serif'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">respectively, </span>of the Company’s total revenue for the <span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span>three months ended September 30, 2024</span></span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"> and </span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>2023</span></span></span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman', 'serif'; line-height: inherit;">, respectively. <span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;">Revenue relating to<span> two</span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;"><span> </span>and<span> one </span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;">customers represented approximately<span> <span style="border-left: none; border-right: none;">75%</span></span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;"> and<span> 97%</span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; line-height: inherit;"> of the Company’s total revenue for the<span> </span></span><span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman', times; float: none; line-height: inherit; display: inline !important;"><span>nine months ended September 30, 2024</span> and <span>2023</span>, respectively.</span></span></span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0in 0in 0in 0.5in; text-align: justify; line-height: 12pt; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">There were no vendors representing 10% or more of the Company’s total cost of revenue for the <span>three and nine</span> months ended <span>September 30, 2024</span> and <span>2023</span>. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers. </span></p>
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
299628 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
819887 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
131388 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
637134 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
168240 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182753 usd
CY2024Q3 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
2970528 usd
CY2023Q4 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
20213733 usd
CY2024Q3 sgbx Provision For Loss On Uncompleted Contracts
ProvisionForLossOnUncompletedContracts
usd
CY2023Q4 sgbx Provision For Loss On Uncompleted Contracts
ProvisionForLossOnUncompletedContracts
usd
CY2024Q3 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-313363 usd
CY2023Q4 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-968040 usd
CY2024Q3 sgbx Contract Assets Gross
ContractAssetsGross
2657165 usd
CY2023Q4 sgbx Contract Assets Gross
ContractAssetsGross
19245693 usd
CY2024Q3 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
3227709 usd
CY2023Q4 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
20601946 usd
CY2024Q3 sgbx Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
-570544 usd
CY2023Q4 sgbx Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
-1356253 usd
CY2024Q3 sgbx Contract With Customer Assets Net Current
ContractWithCustomerAssetsNetCurrent
184520 usd
CY2023Q4 sgbx Contract With Customer Assets Net Current
ContractWithCustomerAssetsNetCurrent
10745 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
755064 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1366998 usd
CY2024Q3 sgbx Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
-570544 usd
CY2023Q4 sgbx Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
-1356253 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4906970 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4899199 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
700655 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
511022 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4206315 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4388177 usd
CY2024Q3 us-gaap Depreciation
Depreciation
104835 usd
CY2023Q3 us-gaap Depreciation
Depreciation
92984 usd
us-gaap Depreciation
Depreciation
189869 usd
us-gaap Depreciation
Depreciation
277573 usd
CY2023 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Writeoff
DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff
750000 usd
CY2023 us-gaap Debt Securities Held To Maturity Accrued Interest Writeoff
DebtSecuritiesHeldToMaturityAccruedInterestWriteoff
129418 usd
CY2021Q4 sgbx Principal Amount Of Promissory Note
PrincipalAmountOfPromissoryNote
750000 usd
CY2021Q4 sgbx Value Of Renovation Improvements
ValueOfRenovationImprovements
750000 usd
CY2021Q4 sgbx Size Of Manufacturing Facility
SizeOfManufacturingFacility
58,000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6679019 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4216417 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
113214 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
107819 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
6565805 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4108598 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1845611 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1661183 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4720194 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2447415 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1120337 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
265627 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2024Q3 sgbx Total Finance Lease Liabilities
TotalFinanceLeaseLiabilities
265627 usd
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y5M1D
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.03 pure
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
133645 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
133645 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
267290 usd
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
1663 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
265627 usd
CY2023Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
1902332 usd
CY2022Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
6810762 usd
sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
4022954 usd
CY2023 sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
11614650 usd
sgbx Adjustments And Cancellations Net
AdjustmentsAndCancellationsNet
73381 usd
CY2023 sgbx Adjustments And Cancellations Net
AdjustmentsAndCancellationsNet
usd
sgbx Construction Backlog Gross
ConstructionBacklogGross
5851905 usd
CY2023 sgbx Construction Backlog Gross
ConstructionBacklogGross
18425412 usd
sgbx Contract Revenue
ContractRevenue
3932592 usd
CY2023 sgbx Contract Revenue
ContractRevenue
16523080 usd
CY2024Q3 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
1919313 usd
CY2023Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
1902332 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1919313 usd
CY2021Q4 sgbx Gross Proceeds
GrossProceeds
11550000 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
10500000 usd
sgbx Stock Issued During Period Shares Under Economic Partnership Agreement
StockIssuedDuringPeriodSharesUnderEconomicPartnershipAgreement
13355 shares
sgbx Stock Issued During Period Value Under Economic Partnership Agreement
StockIssuedDuringPeriodValueUnderEconomicPartnershipAgreement
28867 usd
sgbx Stock Issued During Period Shares For Accounts Payable Settlement
StockIssuedDuringPeriodSharesForAccountsPayableSettlement
212248 shares
sgbx Stock Issued During Period Value For Accounts Payable Settlement
StockIssuedDuringPeriodValueForAccountsPayableSettlement
1259681 usd
sgbx Gain On Settlement Of Accounts Payable Related Parties
GainOnSettlementOfAccountsPayableRelatedParties
121834 usd
sgbx Common Stock Deemed Dividends And Other Adjustments
CommonStockDeemedDividendsAndOtherAdjustments
475713 usd
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3590386 usd
sgbx Number Of Prefunded Warrants Exercised
NumberOfPrefundedWarrantsExercised
294310 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
375000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
375000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.53
CY2024Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
109161 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
251361 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1822 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
496
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1574.2
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M2D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1822 shares
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
496
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1574.2
sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P3Y7M2D
CY2024Q3 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne
usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1822 shares
CY2023Q4 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
496
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1574.2
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1822 shares
CY2024Q3 sgbx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
496
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1574.2
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
109666 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
462466 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
450060 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
12406 shares
CY2018Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
761401.66 usd
CY2020Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
2861401.66 usd

Files In Submission

Name View Source Status
0001213900-24-102979-index-headers.html Edgar Link pending
0001213900-24-102979-index.html Edgar Link pending
0001213900-24-102979.txt Edgar Link pending
0001213900-24-102979-xbrl.zip Edgar Link pending
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgbx-20240930.htm Edgar Link pending
sgbx-20240930.xsd Edgar Link pending
Show.js Edgar Link pending
sgbx-20240930_def.xml Edgar Link unprocessable
sgbx-20240930_pre.xml Edgar Link unprocessable
sgbx-20240930_lab.xml Edgar Link unprocessable
sgbx-20240930_htm.xml Edgar Link completed
sgbx-20240930_cal.xml Edgar Link unprocessable